Original-Research: elumeo SE - von NuWays AG Einstufung von NuWays AG zu elumeo SE Unternehmen: elumeo SE ISIN: DE000A11Q059 Anlass der Studie: Empfehlung: BUY seit: 02.02.2024 Kursziel: 5.00 Kursziel auf Sicht von: 12 Monate Letzte Ratingänderung: Analyst: Mark-Hendrik Schüssler Progress & outlook on jooli.

Original-Research: elumeo SE (von NuWays AG): BUY

Original-Research: elumeo SE - von NuWays AG

Einstufung von NuWays AG zu elumeo SE

Unternehmen: elumeo SE
ISIN: DE000A11Q059

Anlass der Studie: 
Empfehlung: BUY
seit: 02.02.2024
Kursziel: 5.00
Kursziel auf Sicht von: 12 Monate
Letzte Ratingänderung: 
Analyst: Mark-Hendrik Schüssler

Progress & outlook on jooli. Launched in the Indian market to capitalize on
both lower customer acquisition
costs and and a trove of data needed to enhance the app's algorithm, jooli
has already witnessed a
considerable boost in order volume (+560% in December vs. the previous
month), aided by
jooliPay. While first KPIs are promising, they are not yet meaningful, and
hence we do not expect material
top or bottom line contributions from jooli before 2026e, leading us to
adjust our estimates accordingly.
FY'23e preview & long-term growth. As we expect Q4 sales to be burdened by
the muted consumer
sentiment witnessed over the last quarters, and hence softer-than-expected
revenues from the holiday
season, we trimmed our estimates: Q4 sales are now seen to come in at c. EUR
11.3m (flat yoy), implying
sales of EUR 44.7m for the full year (-3% yoy; eNuW old: EUR 45.3m), largely
driven by a lower average sales
price of EUR 67 (-7% yoy) as customers postpone big ticket items sales, and
only partial recovery of items
sold to 168k (+7% yoy). While the weaker-than-expected top line will likely
be affected by a weaker-thanexpected top line, the company's cost cutting
program should continue to bear fruit and thus partially
offset a lacking fixed cost coverage. EBIT should hence run to c. EUR -0.13m
for Q4'23
(+89% yoy) and c. EUR -1.2m for the full year (+17% yoy; eNuW old: EUR -0.8m).
 
Convertible bond financing. In Q4'23, elumeo was able to secure a favorable
5-year convertible debt
financing of c. EUR 1.2m at a 3.8% interest rate from selected suppliers of
the company. The out-of-themoney
strike price (EUR 4.50) along with the belowthe-market interest rate provide
elumeo with a cash infusion
that should give elumeo room to maneuver and to focus on its long-term
growth initiative #juwelo100.
 
The outlook for the long term remains bright. As the company prepares jooli
for a successful roll-out
in its European markets, elumeo's core business is well-positioned to
capitalize on an eventual recovery
of the jewelry and overall e-commerce market, with sales prices and items
sold likely to recover to their
historical means. Overall, elumeo looks set to grow sales by 7% CAGR to c.
EUR 55m by FY'26e along with
reaching a healthy EBIT margin of c. 3% in FY'26e (eNuW), supported by
scale efficiencies. Mind you,
that positive effects stemming from the jooli roll-out are not reflected in
our estimates.
 
BUY with a changed PT of EUR 5.00 based on DCF.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28785.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: [e-mail]
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.